Lv1
35 积分 2021-02-22 加入
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
28天前
已完结
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy
28天前
已完结
Balancing weight and muscle loss in GLP1 receptor agonist therapy
2个月前
已完结
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
2个月前
已完结
Discovery of a novel and potent antiplatelet thiol prodrug CG-0255
2个月前
已完结
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
3个月前
已完结
Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints
3个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
4个月前
已完结
Venture Capital Investment in Neurology Companies
4个月前
已完结
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor
4个月前
已完结
皖公网安备34019202002308
